- Barca's Olmo absence 'better' for us: Athletic coach Valverde
- Jean-Marie Le Pen, architect of French far-right surge, dies at 96
- Spurs boss Postecoglou not in favour of VAR stadium announcements
- Meta abruptly ends US fact-checks ahead of Trump term
- Quake in China's Tibet kills 126 with tremors felt in Nepal, India
- Trump Jr in Greenland on 'tourist' day trip as father eyes territory
- Postecoglou wants trophy for Son as Spurs extend contract
- Loeb limps home as teenager wins Dakar stage
- US trade deficit widens in November on imports jump
- Macron irks allies, left with Africa 'forgot to say thank you' jibe
- Key dates in the rise of the French far right
- Meta announces ending fact-checking program in the US
- Liverpool's Slot says contract issues not affecting Alexander-Arnold's form
- Ghana's John Mahama sworn in after presidential comeback
- Hundreds of young workers sue McDonald's UK alleging harassment
- Jabeur beats Collins to step up comeback ahead of Melbourne
- Eurozone inflation rises, likely forcing slower ECB rate cuts
- France remembers Charlie Hebdo attacks 10 years on
- Microsoft announces $3 bn AI investment in India
- French far-right figurehead Jean-Marie Le Pen dies at 96
- South Korea investigators get new warrant to arrest President Yoon
- French far-right figurehead Jean-Marie Le Pen dies
- South Sudan says will resume oil production from Jan 8
- Pope names Sister Brambilla to head major Vatican office
- Stock markets mostly rise on US optimism
- Olmo's Barcelona registration battle puts Laporta under pressure
- Taste of 2034 World Cup as Saudi Asian Cup stadiums named
- Eurozone inflation picks up in December
- France flanker Ollivon out for season, to miss Six Nations
- S. Korea investigators get new warrant to arrest President Yoon
- Tottenham trigger Son contract extension
- China's most successful team kicked out of professional football
- Eyeing green legacy, Biden declares new national monuments
- South Korea rival parties form plane crash task force
- Georgians hold anti-government protest on Orthodox Christmas
- Japan actor fired from beer ad after drunken escapade
- Nvidia ramps up AI tech for games, robots and autos
- Blinken says US-Japan ties solid despite rift over steel deal
- Quake in China's Tibet kills 95 with tremors felt in Nepal, India
- Taiwan says Chinese-owned ship suspected of damaging sea cable goes dark
- North Korea's Kim says new hypersonic missile will deter 'rivals'
- Sinner turns focus to Australian Open defence after 'amazing' year
- Ostapenko begins Adelaide title defence with comeback win
- Asian markets mostly up after tech-fuelled Wall St rally
- Pace of German emissions cuts slows in 2024: study
- McDonald's rolls back some of its diversity practices
- Giannis triple-double propels Bucks over Raptors
- S. Korea rival parties form plane crash task force despite political turmoil
- Quake in China's Tibet kills 53 with tremors felt in Nepal, India
- Olmo situation overshadowing Barca bid for Spanish Super Cup
JRI | -1.72% | 12.24 | $ | |
CMSD | -0.47% | 23.62 | $ | |
SCS | -1.42% | 11.28 | $ | |
BCC | -1.61% | 118.31 | $ | |
BCE | 0.13% | 23.971 | $ | |
RIO | 0.32% | 58.57 | $ | |
NGG | 0.39% | 59.1 | $ | |
CMSC | -0.36% | 23.405 | $ | |
AZN | 0.22% | 66.985 | $ | |
RBGPF | -4.54% | 59.31 | $ | |
GSK | 0.96% | 34.29 | $ | |
BTI | -0.11% | 36.93 | $ | |
RYCEF | 1.53% | 7.2 | $ | |
RELX | 0.74% | 45.99 | $ | |
VOD | -0.41% | 8.435 | $ | |
BP | 1.52% | 31.5 | $ |
Vibrating pill, ingestible sensor: mini robots tackle gut disorders
A pill that vibrates to relieve constipation, a sensor that can be tracked in the gut -- medical researchers are turning to tiny robots to treat or diagnose gastrointestinal disorders.
"This is a very booming field," said Saransh Sharma, a doctoral student at the California Institute of Technology (Caltech) involved in the development of the ingestible diagnostic sensor.
"You have medical robots that are so small you can just send them inside a person using the oral passage and they can do a lot of sensing and actuation inside the gut," Sharma told AFP.
About 16 of every 100 adults in the United States suffer from symptoms of constipation, according to the US health authorities, and the number doubles for Americans over the age of 60.
Researchers at the Massachusetts Institute of Technology (MIT) and Caltech have developed an ingestible sensor that can be monitored as it travels through the digestive tract.
The device, 20 millimeters in length and eight mm in diameter, could help physicians diagnose gastrointestinal motility disorders that prevent food from moving normally through the digestive tract.
The capsule's location reveals where a slowdown is taking place.
"That gives the doctor a lot of the essential information to do a better job in the curing and the diagnosis and the treatment plan," Sharma said.
The sensor could also provide an alternative to invasive procedures such as endoscopy or other diagnostic techniques such as nuclear imaging, X-rays or catheters.
It has been tested on pigs and the team behind the research hopes to eventually obtain the approval of the US Food and Drug Administration for human clinical trials.
"If we can demonstrate a device inside large animals like pigs up to a very high confidence, we can say that it will scale very well in human anatomy as well," Sharma said.
The authors published the results of their research on Monday in the journal Nature Electronics.
They said the sensor works by detecting a magnetic field produced by an electromagnetic coil located outside of the body.
The strength of the magnetic field varies with distance from the coil and the sensor's position within the digestive tract can be calculated to within millimeters based on measurement of the magnetic field.
- Vibrating capsule -
While the ingestible sensor is still in the development phase, an Israeli company called Vibrant Gastro recently began marketing a vibrating capsule in the United States designed to relieve chronic constipation.
The drug-free Vibrant capsule is intended for constipation sufferers who have not received bowel relief after a month of laxative treatments. It has been FDA-approved.
In a Phase 3 clinical trial of 300 people, participants who took Vibrant had bowel movements significantly more frequently than those who took a placebo.
The Vibrant capsule produces gentle vibrations to stimulate the colon and increases the number and frequency of bowel movements, according to the manufacturer.
Y.Kobayashi--AMWN